Testosterone Propionate;Estradiol Benzoate

Verify with FDA CVM →

22 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
22
Total Reports
5
Deaths Reported
2270.0%
Death Rate

Active Ingredients

Testosterone Propionate;Estradiol Benzoate

Administration Routes

UnknownSubcutaneous

Species Affected

Cattle 20
Unknown 2

Most Affected Breeds

Mixed (Cattle) 16
Unknown 2
Holstein-Friesian also known as Holstein 2
Aberdeen Angus 1
Cattle (unknown) 1

Most Reported Reactions

Mammary hyperplasia 5
Vaginal prolapse 4
Rectal prolapse 4
Death 4
Death by euthanasia 2
Reduced conception rate 2
Mammary gland disorder NOS 2
Tablets, Abnormal 2
Implant site abscess 2
Lack of efficacy - NOS 2
Increased sexual interest 2
Device Defective NOS 2

Outcome Breakdown

Outcome Unknown
19 (70.4%)
Died
4 (14.8%)
Recovered/Normal
2 (7.4%)
Euthanized
2 (7.4%)

Data Summary

Metric Value
Total adverse event reports 22
Reports involving death 5
Case-fatality rate (reported events) 2270.0%
Distinct species in reports 2
Distinct breeds in reports 5
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Testosterone Propionate;Estradiol Benzoate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 22 adverse event reports referencing Testosterone Propionate;Estradiol Benzoate, including 5 reports in which the animal died — a 2270.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Testosterone Propionate;Estradiol Benzoate. Reported administration routes include Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Testosterone Propionate;Estradiol Benzoate reports are Cattle (20 reports), Unknown (2 reports), with Cattle accounting for the largest share. Within those species, Mixed (Cattle) (16), Unknown (2), Holstein-Friesian also known as Holstein (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Testosterone Propionate;Estradiol Benzoate are Mammary hyperplasia (5), Vaginal prolapse (4), Rectal prolapse (4), Death (4). Of the 27 reports with a coded outcome, Outcome Unknown is the leading category at 70.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Testosterone Propionate;Estradiol Benzoate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial